Breast Cancer Cell Colonization of the Human Bone Marrow Adipose Tissue Niche

Neoplasia (United States)

Volumn 17, Issue 12, 2015, Pages 849-861

  Templeton, Zach S ^a   Lie, Wen Rong ^b   Wang, Weiqi ^c   Rosenberg Hasson, Yael ^c   Alluri, Rajiv V ^a   Tamaresis, John S ^c   Bachmann, Michael H ^a   Lee, Kitty ^d   Maloney, William J ^c   Contag, Christopher H ^a   King, Bonnie L ^a  

^a STANFORD UNIVERSITY   (United States)

^b The EMD Millipore Corporation   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; CYTOKINE; FIREFLY LUCIFERASE; GREEN FLUORESCENT PROTEIN; INTERLEUKIN 1BETA; LEPTIN; CONDITIONED MEDIUM; LUCIFERASE;

ADIPOCYTE; ADIPOSE TISSUE; ADULT; ARTICLE; BIOLUMINESCENCE; BONE MARROW; BONE METASTASIS; BONE TISSUE; BREAST CANCER; CANCER CELL; CELL MIGRATION; CLINICAL ARTICLE; COCULTURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIFFUSION CHAMBER; FEMALE; FEMUR HEAD; FILTERS AND MEMBRANES; FLUORESCENCE MICROSCOPY; HIP ARTHROPLASTY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOASSAY; IMMUNOHISTOCHEMISTRY; MALE; MCF 7 CELL LINE; MULTIVARIATE ANALYSIS; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGRESSION ANALYSIS; STATISTICAL ANALYSIS; TRABECULAR BONE; TROPISM; UNIVARIATE ANALYSIS; BONE; BREAST TUMOR; CELL ADHESION; CELL MOTION; CELL PROLIFERATION; CONDITIONED MEDIUM; CONFOCAL MICROSCOPY; GENETICS; MCF-7 CELL LINE; METABOLISM; PATHOLOGY; STATISTICAL MODEL; TUMOR CELL LINE; TUMOR MICROENVIRONMENT;

ADIPOCYTES; ADIPOSE TISSUE; BONE AND BONES; BONE MARROW; BREAST NEOPLASMS; CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CELLULAR MICROENVIRONMENT; COCULTURE TECHNIQUES; CULTURE MEDIA, CONDITIONED; FEMALE; GREEN FLUORESCENT PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-1BETA; LEPTIN; LOGISTIC MODELS; LUCIFERASES; MALE; MCF-7 CELLS; MICROSCOPY, CONFOCAL; MICROSCOPY, FLUORESCENCE; MULTIVARIATE ANALYSIS;

EID: 84963984027     PISSN: 15228002     EISSN: 14765586     Source Type: Journal    
DOI: 10.1016/j.neo.2015.11.005     Document Type: Article

References (87)

1. Coleman RE, Rubens RD The clinical course of bone metastases from breast cancer. Br J Cancer 1987, 55(1):61-66. [Epub 1987/01/01. PubMed PMID: 3814476].
2. Mundy GR Metastasis to bone: causes, consequences and therapeutic opportunities. Nat Rev Cancer 2002, 2(8):584-593. [Epub 2002/08/03, PubMed PMID: 12154351]. 10.1038/nrc867.
3. Paget S The distribution of secondary growths in cancer of the breast. Cancer Metastasis Rev 1989, 8(2):98-101. [PubMed PMID: 2673568].
4. Fidler IJ The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat Rev Cancer 2003, 3(6):453-458. [PubMed PMID: 12778135]. 10.1038/nrc1098.
5. Mastro AM, Gay CV, Welch DR The skeleton as a unique environment for breast cancer cells. Clin Exp Metastasis 2003, 20(3):275-284. [PubMed PMID: 12741685].
6. Yoneda T Arterial microvascularization and breast cancer colonization in bone. Histol Histopathol 1997, 12(4):1145-1149. [PubMed PMID: 9302573].
7. Bersini S, Jeon JS, Dubini G, Arrigoni C, Chung S, Charest JL, Moretti M, Kamm RD A microfluidic 3D in vitro model for specificity of breast cancer metastasis to bone. Biomaterials 2014, 35(8):2454-2461. [Epub 2014/01/07, PubMed PMID: 24388382; PMCID: 3905838]. 10.1016/j.biomaterials.2013.11.050.
8. Bussard KM, Venzon DJ, Mastro AM Osteoblasts are a major source of inflammatory cytokines in the tumor microenvironment of bone metastatic breast cancer. J Cell Biochem 2010, 111(5):1138-1148. [Epub 2010/08/05, PubMed PMID: 20683902]. 10.1002/jcb.22799.
9. Chen X, Lu J, Ji Y, Hong A, Xie Q Cytokines in osteoblast-conditioned medium promote the migration of breast cancer cells. Tumour Biol 2014, 35(1):791-798. [PubMed PMID: 24026883]. 10.1007/s13277-013-1109-0.
10. Jones DH, Nakashima T, Sanchez OH, Kozieradzki I, Komarova SV, Sarosi I, Morony S, Rubin E, Sarao R, Hojilla CV, et al. Regulation of cancer cell migration and bone metastasis by RANKL. Nature 2006, 440(7084):692-696. [PubMed PMID: 16572175]. 10.1038/nature04524.
11. Kapoor P, Suva LJ, Welch DR, Donahue HJ Osteoprotegrin and the bone homing and colonization potential of breast cancer cells. J Cell Biochem 2008, 103(1):30-41. [PubMed PMID: 17471510]. 10.1002/jcb.21382.
12. Koro K, Parkin S, Pohorelic B, Yang AD, Narendran A, Egan C, Magliocco A Interactions between breast cancer cells and bone marrow derived cells in vitro define a role for osteopontin in affecting breast cancer cell migration. Breast Cancer Res Treat 2011, 126(1):73-83. [Epub 2010/04/20, PubMed PMID: 20401631]. 10.1007/s10549-010-0889-9.
13. Martinez LM, Vallone VB, Labovsky V, Choi H, Hofer EL, Feldman L, Bordenave RH, Batagelj E, Dimase F, Villafane AR, et al. Changes in the peripheral blood and bone marrow from untreated advanced breast cancer patients that are associated with the establishment of bone metastases. Clin Exp Metastasis 2014, 31(2):213-232. [PubMed PMID: 24173696]. 10.1007/s10585-013-9622-5.
14. Muller A, Homey B, Soto H, Ge N, Catron D, Buchanan ME, McClanahan T, Murphy E, Yuan W, Wagner SN, et al. Involvement of chemokine receptors in breast cancer metastasis. Nature 2001, 410(6824):50-56. [PubMed PMID: 11242036]. 10.1038/35065016.
15. Pohorelic B, Singh R, Parkin S, Koro K, Yang AD, Egan C, Magliocco A Role of Src in breast cancer cell migration and invasion in a breast cell/bone-derived cell microenvironment. Breast Cancer Res Treat 2012, 133(1):201-214. [Epub 2011/09/07, PubMed PMID: 21894461]. 10.1007/s10549-011-1753-2.
16. Zhang L, Teng Y, Zhang Y, Liu J, Xu L, Qu J, Hou K, Yang X, Liu Y, Qu X C-Src-mediated RANKL-induced breast cancer cell migration by activation of the ERK and Akt pathway. Oncol lett 2012, 3(2):395-400. [PubMed PMID: 22740919; PMCID: 3362513]. 10.3892/ol.2011.487.
17. Herroon MK, Rajagurubandara E, Hardaway AL, Powell K, Turchick A, Feldmann D, Podgorski I Bone marrow adipocytes promote tumor growth in bone via FABP4-dependent mechanisms. Oncotarget 2013, 4(11):2108-2123. [PubMed PMID: 24240026; PMCID: 3875773].
18. Shiozawa Y, Eber MR, Berry JE, Taichman RS Bone marrow as a metastatic niche for disseminated tumor cells from solid tumors. BoneKEy rep 2015, 4:689. [PubMed PMID: 26029360; PMCID: 4440229]. 10.1038/bonekey.2015.57.
19. Shiozawa Y, Pedersen EA, Havens AM, Jung Y, Mishra A, Joseph J, Kim JK, Patel LR, Ying C, Ziegler AM, et al. Human prostate cancer metastases target the hematopoietic stem cell niche to establish footholds in mouse bone marrow. J Clin Invest 2011, 121(4):1298-1312. [PubMed PMID: 21436587; PMCID: 3069764]. 10.1172/JCI43414.
20. Ghajar CM, Peinado H, Mori H, Matei IR, Evason KJ, Brazier H, Almeida D, Koller A, Hajjar KA, Stainier DY, et al. The perivascular niche regulates breast tumour dormancy. Nat Cell Biol 2013, 15(7):807-817. PubMed PMID: 23728425; PMCID: 3826912. 10.1038/ncb2767.
21. Wang H, Yu C, Gao X, Welte T, Muscarella AM, Tian L, Zhao H, Zhao Z, Du S, Tao J, et al. The osteogenic niche promotes early-stage bone colonization of disseminated breast cancer cells. Cancer cell 2015, 27(2):193-210. [PubMed PMID: 25600338; PMCID: 4326554]. 10.1016/j.ccell.2014.11.017.
22. Bissell MJ, Radisky D Putting tumours in context. Nat Rev Cancer 2001, 1(1):46-54. [Epub 2002/03/20, PubMed PMID: 11900251; PMCID: 2975572]. 10.1038/35094059.
23. Joyce JA, Pollard JW Microenvironmental regulation of metastasis. Nat Rev Cancer 2009, 9(4):239-252. [Epub 2009/03/13, PubMed PMID: 19279573; PMCID: 3251309]. 10.1038/nrc2618.
24. Place AE, Jin Huh S, Polyak K The microenvironment in breast cancer progression: biology and implications for treatment. Breast Cancer Res 2011, 13(6):227. [Epub 2011/11/15, PubMed PMID: 22078026; PMCID: 3326543]. 10.1186/bcr2912.
25. Fazeli PK, Horowitz MC, MacDougald OA, Scheller EL, Rodeheffer MS, Rosen CJ, Klibanski A Marrow fat and bone--new perspectives. J Clin Endocrinol Metab 2013, 98(3):935-945. [PubMed PMID: 23393168; PMCID: 3590487]. 10.1210/jc.2012-3634.
26. Justesen J, Stenderup K, Ebbesen EN, Mosekilde L, Steiniche T, Kassem M Adipocyte tissue volume in bone marrow is increased with aging and in patients with osteoporosis. Biogerontology 2001, 2(3):165-171. [PubMed PMID: 11708718].
27. Scheller EL, Rosen CJ What's the matter with MAT? Marrow adipose tissue, metabolism, and skeletal health. Ann N Y Acad Sci 2014, 1311:14-30. [PubMed PMID: 24650218; PMCID: 4049420]. 10.1111/nyas.12327.
28. Hardaway AL, Herroon MK, Rajagurubandara E, Podgorski I Bone marrow fat: linking adipocyte-induced inflammation with skeletal metastases. Cancer Metastasis Rev 2014, 33(2-3):527-543. [Epub 2014/01/09, PubMed PMID: 24398857; PMCID: 4154371]. 10.1007/s10555-013-9484-y.
29. Contag CH, Lie WR, Bammer MC, Hardy JW, Schmidt TL, Maloney WJ, King BL Monitoring dynamic interactions between breast cancer cells and human bone tissue in a co-culture model. Mol Imaging Biol 2014, 16(2):158-166. [Epub 2013/09/07, PubMed PMID: 24008275]. 10.1007/s11307-013-0685-0.
30. Templeton ZS, Bachmann MH, Alluri RV, Maloney WJ, Contag CH, King BL Methods for Culturing Human Femur Tissue Explants to Study Breast Cancer Cell Colonization of the Metastatic Niche. J Vis Exp 2015, 97(e52656):1-10. 10.3791/52656.
31. Multhaup M, Karlen AD, Swanson DL, Wilber A, Somia NV, Cowan MJ, McIvor RS Cytotoxicity associated with artemis overexpression after lentiviral vector-mediated gene transfer. Hum Gene Ther 2010, 21(7):865-875. [Epub 2010/02/19, 162. PubMed PMID: 20163250; PMCID: 2938362]. 10.1089/hum.2009.162.
32. Thorne SH, Barak Y, Liang W, Bachmann MH, Rao J, Contag CH, Matin A CNOB/ChrR6, a new prodrug enzyme cancer chemotherapy. Mol Cancer Ther 2009, 8(2):333-341. [Epub 2009/02/05. doi: 1535-7163. MCT-08-0707 [pii] 10.1158/1535-7163.MCT-08-0707. PubMed PMID: 19190118].
33. Liu X, Ory V, Chapman S, Yuan H, Albanese C, Kallakury B, Timofeeva OA, Nealon C, Dakic A, Simic V, et al. ROCK inhibitor and feeder cells induce the conditional reprogramming of epithelial cells. Am J Pathol 2012, 180(2):599-607. [Epub 2011/12/23, PubMed PMID: 22189618; PMCID: 3349876]. 10.1016/j.ajpath.2011.10.036.
34. Rosenberg-Hasson Y, Hansmann L, Liedtke M, Herschmann I, Maecker HT Effects of serum and plasma matrices on multiplex immunoassays. Immunol Res 2014, 58(2-3):224-233. [PubMed PMID: 24522699; PMCID: 4332596]. 10.1007/s12026-014-8491-6.
35. Johansson JU, Pradhan S, Lokteva LA, Woodling NS, Ko N, Brown HD, Wang Q, Loh C, Cekanaviciute E, Buckwalter M, et al. Suppression of inflammation with conditional deletion of the prostaglandin E2 EP2 receptor in macrophages and brain microglia. J Neurosci 2013, 33(40):16016-16032. [PubMed PMID: 24089506; PMCID: 3787507]. 10.1523/JNEUROSCI.2203-13.2013.
36. Team RC R: A language and environment for statistical computing. Foundation for Statistical Computing 2012.
37. Bates DM, Maechler M, Bolker B lmme4: Linear mixed-effects models using S4 classes. R package version 0.999999-0 2012.
38. Kim IS, Baek SH Mouse models for breast cancer metastasis. Biochem Biophys Res Commun 2010, 394(3):443-447. [Epub 2010/03/17, PubMed PMID: 20230796]. 10.1016/j.bbrc.2010.03.070.
39. Nutter F, Holen I, Brown HK, Cross SS, Evans CA, Walker M, Coleman RE, Westbrook JA, Selby PJ, Brown JE, et al. Different molecular profiles are associated with breast cancer cell homing compared with colonisation of bone: evidence using a novel bone-seeking cell line. Endocr Relat Cancer 2014, 21(2):327-341. [PubMed PMID: 24413608]. 10.1530/ERC-13-0158.
40. Riccio AI, Wodajo FM, Malawer M Metastatic carcinoma of the long bones. Am Fam Physician 2007, 76(10):1489-1494. [Epub 2007/12/07, PubMed PMID: 18052014].
41. Vande Berg BC, Malghem J, Lecouvet FE, Maldague B Magnetic resonance imaging of normal bone marrow. Eur Radiol 1998, 8(8):1327-1334. [PubMed PMID: 9853209]. 10.1007/s003300050547.
42. Hwang S, Panicek DM Magnetic resonance imaging of bone marrow in oncology, Part 1. Skeletal Radiol 2007, 36(10):913-920. [PubMed PMID: 17492443]. 10.1007/s00256-007-0309-3.
43. Wiseman BS, Werb Z Stromal effects on mammary gland development and breast cancer. Science 2002, 296(5570):1046-1049. [PubMed PMID: 12004111; PMCID: 2788989]. 10.1126/science.1067431.
44. Gnerlich JL, Yao KA, Fitchev PS, Goldschmidt RA, Bond MC, Cornwell M, Crawford SE Peritumoral expression of adipokines and fatty acids in breast cancer. Ann Surg Oncol 2013, 20(Suppl 3):S731-S738. [PubMed PMID: 24052317]. 10.1245/s10434-013-3274-1.
45. Iyengar P, Combs TP, Shah SJ, Gouon-Evans V, Pollard JW, Albanese C, Flanagan L, Tenniswood MP, Guha C, Lisanti MP, et al. Adipocyte-secreted factors synergistically promote mammary tumorigenesis through induction of anti-apoptotic transcriptional programs and proto-oncogene stabilization. Oncogene 2003, 22(41):6408-6423. [PubMed PMID: 14508521]. 10.1038/sj.onc.1206737.
46. Liu E, Samad F, Mueller BM Local adipocytes enable estrogen-dependent breast cancer growth: Role of leptin and aromatase. Adipocyte 2013, 2(3):165-169. [PubMed PMID: 23991363; PMCID: 3756105]. 10.4161/adip.23645.
47. Landskroner-Eiger S, Park J, Israel D, Pollard JW, Scherer PE Morphogenesis of the developing mammary gland: stage-dependent impact of adipocytes. Dev Biol 2010, 344(2):968-978. [PubMed PMID: 20599899; PMCID: 2917626]. 10.1016/j.ydbio.2010.06.019.
48. Dirat B, Bochet L, Dabek M, Daviaud D, Dauvillier S, Majed B, Wang YY, Meulle A, Salles B, Le Gonidec S, et al. Cancer-associated adipocytes exhibit an activated phenotype and contribute to breast cancer invasion. Cancer Res 2011, 71(7):2455-2465. [PubMed PMID: 21459803]. 10.1158/0008-5472.CAN-10-3323.
49. Park J, Morley TS, Kim M, Clegg DJ, Scherer PE Obesity and cancer--mechanisms underlying tumour progression and recurrence. Nat Rev Endocrinol 2014, 10(8):455-465. [PubMed PMID: 24935119; PMCID: 4374431]. 10.1038/nrendo.2014.94.
50. Khan S, Shukla S, Sinha S, Meeran SM Role of adipokines and cytokines in obesity-associated breast cancer: therapeutic targets. Cytokine Growth Factor Rev 2013, 24(6):503-513. [PubMed PMID: 24210902]. 10.1016/j.cytogfr.2013.10.001.
51. Garcia-Robles MJ, Segura-Ortega JE, Fafutis-Morris M The biology of leptin and its implications in breast cancer: a general view. J Interferon Cytokine Res 2013, 33(12):717-727. [Epub 2013/07/23, PubMed PMID: 23869900]. 10.1089/jir.2012.0168.
52. Niu J, Jiang L, Guo W, Shao L, Liu Y, Wang L The Association between Leptin Level and Breast Cancer: A Meta-Analysis. PloS one 2013, 8(6):e67349. [PubMed PMID: 23826274; PMCID: 3694967]. 10.1371/journal.pone.0067349.
53. Saxena NK, Sharma D Multifaceted leptin network: the molecular connection between obesity and breast cancer. J Mammary Gland Biol Neoplasia 2013, 18(3-4):309-320. [PubMed PMID: 24214584]. 10.1007/s10911-013-9308-2.
54. Schmidt S, Monk JM, Robinson LE, Mourtzakis M The integrative role of leptin, oestrogen and the insulin family in obesity-associated breast cancer: potential effects of exercise. Obes Rev 2015, 16(6):473-487. [PubMed PMID: 25875578]. 10.1111/obr.12281.
55. Ando S, Barone I, Giordano C, Bonofiglio D, Catalano S The Multifaceted Mechanism of Leptin Signaling within Tumor Microenvironment in Driving Breast Cancer Growth and Progression. Front oncol 2014, 4:340. [PubMed PMID: 25505738; PMCID: 4245002]. 10.3389/fonc.2014.00340.
56. Romero-Figueroa Mdel S, Garduno-Garcia Jde J, Duarte-Mote J, Matute-Gonzalez G, Gomez-Villanueva A, De la Cruz-Vargas J Insulin and leptin levels in obese patients with and without breast cancer. Clin Breast Cancer 2013, 13(6):482-485. [Epub 2013/10/03, PubMed PMID: 24084031]. 10.1016/j.clbc.2013.08.001.
57. Delort L, Rossary A, Farges MC, Vasson MP, Caldefie-Chezet F Leptin, adipocytes and breast cancer: Focus on inflammation and anti-tumor immunity. Life Sci 2015, 140:37-48. [PubMed PMID: 25957709]. 10.1016/j.lfs.2015.04.012.
58. Garofalo C, Koda M, Cascio S, Sulkowska M, Kanczuga-Koda L, Golaszewska J, Russo A, Sulkowski S, Surmacz E Increased expression of leptin and the leptin receptor as a marker of breast cancer progression: possible role of obesity-related stimuli. Clin Cancer Res 2006, 12(5):1447-1453. [Epub 2006/03/15, PubMed PMID: 16533767]. 10.1158/1078-0432.CCR-05-1913.
59. Ishikawa M, Kitayama J, Nagawa H Enhanced expression of leptin and leptin receptor (OB-R) in human breast cancer. Clin Cancer Res 2004, 10(13):4325-4331. [PubMed PMID: 15240518]. 10.1158/1078-0432.CCR-03-0749.
60. Miyoshi Y, Funahashi T, Tanaka S, Taguchi T, Tamaki Y, Shimomura I, Noguchi S High expression of leptin receptor mRNA in breast cancer tissue predicts poor prognosis for patients with high, but not low, serum leptin levels. Int J Cancer 2006, 118(6):1414-1419. [PubMed PMID: 16206269]. 10.1002/ijc.21543.
61. Zheng Q, Dunlap SM, Zhu J, Downs-Kelly E, Rich J, Hursting SD, Berger NA, Reizes O Leptin deficiency suppresses MMTV-Wnt-1 mammary tumor growth in obese mice and abrogates tumor initiating cell survival. Endocr Relat Cancer 2011, 18(4):491-503. [Epub 2011/06/04, PubMed PMID: 21636700; PMCID: 3197719]. 10.1530/ERC-11-0102.
62. Dieudonne MN, Machinal-Quelin F, Serazin-Leroy V, Leneveu MC, Pecquery R, Giudicelli Y Leptin mediates a proliferative response in human MCF7 breast cancer cells. Biochem Biophys Res Commun 2002, 293(1):622-628. [Epub 2002/06/11, PubMed PMID: 12054648]. 10.1016/S0006-291X(02)00205-X.
63. Fusco R, Galgani M, Procaccini C, Franco R, Pirozzi G, Fucci L, Laccetti P, Matarese G Cellular and molecular crosstalk between leptin receptor and estrogen receptor-{alpha} in breast cancer: molecular basis for a novel therapeutic setting. Endocr Relat Cancer 2010, 17(2):373-382. [Epub 2010/04/23, PubMed PMID:20410173]. 10.1677/ERC-09-0340.
64. Ray A, Nkhata KJ, Cleary MP Effects of leptin on human breast cancer cell lines in relationship to estrogen receptor and HER2 status. Int J Oncol 2007, 30(6):1499-1509. [Epub 2007/05/10, PubMed PMID:17487372].
65. Yuan HJ, Sun KW, Yu K Leptin promotes the proliferation and migration of human breast cancer through the extracellular-signal regulated kinase pathway. Mol Med Rep 2014, 9(1):350-354. [Epub 2013/11/12, PubMed PMID: 24213635]. 10.3892/mmr.2013.1786.
66. Strong AL, Ohlstein JF, Biagas BA, Rhodes LV, Pei DT, Tucker HA, Llamas C, Bowles AC, Dutreil MF, Zhang S, et al. Leptin produced by obese adipose stromal/stem cells enhances proliferation and metastasis of estrogen receptor positive breast cancers. Breast Cancer Res 2015, 17:112. [PubMed PMID: 26286584; PMCID: 4541745]. 10.1186/s13058-015-0622-z.
67. Dubois V, Jarde T, Delort L, Billard H, Bernard-Gallon D, Berger E, Geloen A, Vasson MP, Caldefie-Chezet F Leptin induces a proliferative response in breast cancer cells but not in normal breast cells. Nutr Cancer 2014, 66(4):645-655. [Epub 2014/04/18, PubMed PMID: 24738610]. 10.1080/01635581.2014.894104.
68. Kim SH, Nagalingam A, Saxena NK, Singh SV, Sharma D Benzyl isothiocyanate inhibits oncogenic actions of leptin in human breast cancer cells by suppressing activation of signal transducer and activator of transcription 3. Carcinogenesis 2011, 32(3):359-367. [PubMed PMID: 21163886; PMCID: 3105585]. 10.1093/carcin/bgq267.
69. Wang L, Tang C, Cao H, Li K, Pang X, Zhong L, Dang W, Tang H, Huang Y, Wei L, et al. Activation of IL-8 via PI3K/Akt-dependent pathway is involved in leptin-mediated epithelial-mesenchymal transition in human breast cancer cells. Cancer Biol Ther 2015, 16(8):1220-1230. [PubMed PMID: 26121010]. 10.1080/15384047.2015.1056409.
70. Wolfson B, Eades G, Zhou Q Adipocyte activation of cancer stem cell signaling in breast cancer. World J Biol Chem 2015, 6(2):39-47. [PubMed PMID: 26009703; PMCID: 4436905]. 10.4331/wjbc.v6.i2.39.
71. Elaraj DM, Weinreich DM, Varghese S, Puhlmann M, Hewitt SM, Carroll NM, Feldman ED, Turner EM, Alexander HR The role of interleukin 1 in growth and metastasis of human cancer xenografts. Clin Cancer Res 2006, 12(4):1088-1096. [PubMed PMID: 16489061]. 10.1158/1078-0432.CCR-05-1603.
72. Apte RN, Krelin Y, Song X, Dotan S, Recih E, Elkabets M, Carmi Y, Dvorkin T, White RM, Gayvoronsky L, et al. Effects of micro-environment- and malignant cell-derived interleukin-1 in carcinogenesis, tumour invasiveness and tumour-host interactions. Eur J Cancer 2006, 42(6):751-759. [PubMed PMID: 16530403]. 10.1016/j.ejca.2006.01.010.
73. Margetic S, Gazzola C, Pegg GG, Hill RA Leptin: a review of its peripheral actions and interactions. Int J Obes Relat Metab Disord 2002, 26(11):1407-1433. [PubMed PMID: 12439643]. 10.1038/sj.ijo.0802142.
74. Masuzaki H, Ogawa Y, Isse N, Satoh N, Okazaki T, Shigemoto M, Mori K, Tamura N, Hosoda K, Yoshimasa Y, et al. Human obese gene expression. Adipocyte-specific expression and regional differences in the adipose tissue. Diabetes 1995, 44(7):855-858. [PubMed PMID: 7789654].
75. Laharrague P, Larrouy D, Fontanilles AM, Truel N, Campfield A, Tenenbaum R, Galitzky J, Corberand JX, Penicaud L, Casteilla L High expression of leptin by human bone marrow adipocytes in primary culture. FASEB J 1998, 12(9):747-752. [PubMed PMID: 9619453].
76. Kollmer M, Buhrman JS, Zhang Y, Gemeinhart RA Markers Are Shared Between Adipogenic and Osteogenic Differentiated Mesenchymal Stem Cells. J Dev Biol Tissue Eng 2013, 5(2):18-25. [PubMed PMID: 24013643; PMCID: 3765027]. 10.5897/JDBTE2013.0065.
77. Reseland JE, Syversen U, Bakke I, Qvigstad G, Eide LG, Hjertner O, Gordeladze JO, Drevon CA Leptin is expressed in and secreted from primary cultures of human osteoblasts and promotes bone mineralization. J Bone Miner Res 2001, 16(8):1426-1433. [PubMed PMID: 11499865]. 10.1359/jbmr.2001.16.8.1426.
78. Schipper HS, de Jager W, van Dijk ME, Meerding J, Zelissen PM, Adan RA, Prakken BJ, Kalkhoven E A multiplex immunoassay for human adipokine profiling. Clin Chem 2010, 56(8):1320-1328. [PubMed PMID: 20530731]. 10.1373/clinchem.2010.146118.
79. Nieman KM, Kenny HA, Penicka CV, Ladanyi A, Buell-Gutbrod R, Zillhardt MR, Romero IL, Carey MS, Mills GB, Hotamisligil GS, et al. Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth. Nat Med 2011, 17(11):1498-1503. [PubMed PMID: 22037646; PMCID: 4157349]. 10.1038/nm.2492.
80. Nieman KM, Romero IL, Van Houten B, Lengyel E Adipose tissue and adipocytes support tumorigenesis and metastasis. Biochim Biophys Acta 2013, 1831(10):1533-1541. [Epub 2013/03/19, PubMed PMID: 23500888; PMCID: 3742583]. 10.1016/j.bbalip.2013.02.010.
81. Hardaway AL, Herroon MK, Rajagurubandara E, Podgorski I Marrow adipocyte-derived CXCL1 and CXCL2 contribute to osteolysis in metastatic prostate cancer. Clin Exp Metastasis 2015, 32(4):353-368. [PubMed PMID: 25802102; PMCID: 4393805]. 10.1007/s10585-015-9714-5.
82. Ford NA, Devlin KL, Lashinger LM, Hursting SD Deconvoluting the obesity and breast cancer link: secretome, soil and seed interactions. J Mammary Gland Biol Neoplasia 2013, 18(3-4):267-275. [Epub 2013/10/05, PubMed PMID: 24091864; PMCID: 3874287]. 10.1007/s10911-013-9301-9.
83. Howe LR, Subbaramaiah K, Hudis CA, Dannenberg AJ Molecular pathways: adipose inflammation as a mediator of obesity-associated cancer. Clin Cancer Res 2013, 19(22):6074-6083. [Epub 2013/08/21, PubMed PMID: 23958744; PMCID: 3891839]. 10.1158/1078-0432.
84. Gross AL, Newschaffer CJ, Hoffman-Bolton J, Rifai N, Visvanathan K Adipocytokines, inflammation, and breast cancer risk in postmenopausal women: a prospective study. Cancer Epidemiol Biomarkers Prev 2013, 22(7):1319-1324. PubMed PMID: 23651666; PMCID: 4417498. 10.1158/1055-9965.EPI-12-1444.
85. Cho YA, Sung MK, Yeon JY, Ro J, Kim J Prognostic role of interleukin-6, interleukin-8, and leptin levels according to breast cancer subtype. Cancer Res Treat 2013, 45(3):210-219. [PubMed PMID: 24155680; PMCID: 3804733]. 10.4143/crt.2013.45.3.210.
86. Khandekar MJ, Cohen P, Spiegelman BM Molecular mechanisms of cancer development in obesity. Nat Rev Cancer 2011, 11(12):886-895. [PubMed PMID: 22113164]. 10.1038/nrc3174.
87. Gunter MJ, Wang T, Cushman M, Xue X, Wassertheil-Smoller S, Strickler HD, Rohan TE, Manson JE, McTiernan A, Kaplan RC, et al. Circulating Adipokines and Inflammatory Markers and Postmenopausal Breast Cancer Risk. J Natl Cancer Inst 2015, 107(9). [PubMed PMID: 26185195]. 10.1093/jnci/djv169.